The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · May 2011
Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest.
Massive perioperative blood product transfusion may be required with thoracic aortic operations and is associated with poor outcomes. We analyzed independent predictors of massive transfusion in thoracic aortic surgical patients undergoing deep hypothermic circulatory arrest. ⋯ Cardiopulmonary bypass time, emergency status, and preoperative hemoglobin were independent predictors of massive transfusion. These variables, along with weight, age, and resternotomy, were associated with total blood product use in thoracic aortic operations involving deep hypothermic circulatory arrest.
-
J. Thorac. Cardiovasc. Surg. · May 2011
Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals.
With cardiothoracic education going through a critical phase of reevaluation and adaptation, we investigated perceptions of Veterans Affairs hospitals in cardiothoracic training. ⋯ These findings suggest that Veterans Affairs hospitals are perceived as providing valuable experience in cardiothoracic training. The results warrant additional studies to further define the educational role of Veterans Affairs hospitals and help shape existing and future collaboration between cardiothoracic residency programs and the Veterans Affairs.
-
J. Thorac. Cardiovasc. Surg. · May 2011
Comparative StudyCone reconstruction of the tricuspid valve in Ebstein anomaly with or without one and a half ventricle repair.
We sought to review our institutional experience and midterm results with cone reconstruction in Ebstein anomaly with or without one and a half ventricle repair to evaluate these 2 important surgical methods for the treatment of Ebstein anomaly. ⋯ Addition of a bidirectional cavopulmonary shunt to cone reconstruction of the tricuspid valve should be considered for young patients with severe Ebstein anomaly who are at high risk of right ventricular failure after the operation.
-
J. Thorac. Cardiovasc. Surg. · May 2011
Review Meta AnalysisDrug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.
We performed the present systematic review and meta-analysis of randomized and nonrandomized comparative studies in an attempt to compare the safety and efficacy of drug-eluting stents with coronary artery bypass grafting for patients with coronary artery disease. ⋯ Drug-eluting stents are associated with less periprocedural risks but a higher incidence of postprocedural myocardial infarction, repeat revascularization, and 12-month major adverse cardiac and cerebrovascular events compared with coronary artery bypass grafting.